195 related articles for article (PubMed ID: 32880829)
1. Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.
Isabel Cristina RS; Diana A; Karen A
Mycopathologia; 2020 Dec; 185(6):1069-1076. PubMed ID: 32880829
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough Invasive Sinusitis by Hormographiella aspergillata in a Neutropenic Patient Receiving Voriconazole Therapy: A Case Report and Review of Breakthrough H. aspergillata Infections.
Florez-Riaño AF; Ramírez-Sánchez IC
Mycopathologia; 2023 Aug; 188(4):401-407. PubMed ID: 37389746
[TBL] [Abstract][Full Text] [Related]
3. Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient.
Heiblig M; Bozzoli V; Saison J; Thomas X; De Croze D; Traverse-Glehen A; Cosmidis A; Chidiac C; Ferry T; Alanio A; Bienvenu AL; Dupont D; Ducastelle-Lepretre S; Michallet M; Ader F;
Mycoses; 2015 May; 58(5):308-12. PubMed ID: 25752189
[TBL] [Abstract][Full Text] [Related]
4. Hormographiella aspergillata pulmonary infections: Detection and identification of the fungus using pan-fungal PCR assays and DNA sequencing.
Nevez G; Guillerm G; Talarmin JP; Quinio D; Iriart X; Lissillour PL; Rezig S; Fangous MS; Ranty M; Bodenes L; Aubron C; Couturier MA; Le Gal S
J Mycol Med; 2024 Mar; 34(1):101463. PubMed ID: 38342037
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
Copley MS; Waldron M; Athans V; Welch SC; Brizendine KD; Cober E; Siebenaller C
Int J Antimicrob Agents; 2020 Mar; 55(3):105886. PubMed ID: 31926286
[TBL] [Abstract][Full Text] [Related]
8. Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.
Bojic M; Willinger B; Rath T; Tobudic S; Thalhammer F; Böhm A; Mitterbauer M; Schulenburg A; Wöhrer S; Kalhs P; Rabitsch W
Mycoses; 2013 Nov; 56(6):687-9. PubMed ID: 23672484
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
Cho SY; Lee DG; Choi SM; Choi JK; Lee HJ; Kim SH; Park SH; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS
Mycoses; 2015 Sep; 58(9):565-71. PubMed ID: 26214656
[TBL] [Abstract][Full Text] [Related]
10. The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study.
Özkocaman V; Özkalemkaş F; Seyhan S; Ener B; Ursavaş A; Ersal T; Kazak E; Demirdöğen E; Mıstık R; Akalın H
Turk J Haematol; 2018 Nov; 35(4):277-282. PubMed ID: 30047484
[TBL] [Abstract][Full Text] [Related]
11. SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Busca A; Lessi F; Verga L; Candoni A; Cattaneo C; Cesaro S; Dragonetti G; Delia M; De Luca A; Guglielmi G; Tumbarello M; Martino G; Nadali G; Fanci R; Picardi M; Potenza L; Nosari A; Aversa F; Pagano L;
Leuk Lymphoma; 2017 Dec; 58(12):2859-2864. PubMed ID: 28508692
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.
Suarez F; Olivier G; Garcia-Hermoso D; Randriamalala E; Ghez D; Bruneau J; Kauffmann-Lacroix C; Bougnoux ME; Lortholary O
J Clin Microbiol; 2011 Jan; 49(1):461-5. PubMed ID: 21068290
[TBL] [Abstract][Full Text] [Related]
13. Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review.
Moniot M; Lavergne RA; Morel T; Guieze R; Morio F; Poirier P; Nourrisson C
BMC Infect Dis; 2020 Dec; 20(1):945. PubMed ID: 33308180
[TBL] [Abstract][Full Text] [Related]
14. Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia.
Devanlay C; Tavernier-Tardy E; Bourmaud A; Falk AT; Raberin H; Menguy S; Guyotat D; Magné N; Cornillon J
Biomed J; 2015; 38(3):235-43. PubMed ID: 25355388
[TBL] [Abstract][Full Text] [Related]
15. Ocular infection caused by Hormographiella aspergillata: A case report and review of literature.
Jain N; Jinagal J; Kaur H; Ghosh A; Gupta S; Ram J; Rudramurthy SM
J Mycol Med; 2019 Apr; 29(1):71-74. PubMed ID: 30630667
[TBL] [Abstract][Full Text] [Related]
16. Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
Phillips K; Cirrone F; Ahuja T; Siegfried J; Papadopoulos J
J Oncol Pharm Pract; 2019 Mar; 25(2):398-403. PubMed ID: 30319061
[TBL] [Abstract][Full Text] [Related]
17. Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Wong GC; Abdul Halim NA; Tan BH
Clin Infect Dis; 2015 Oct; 61(8):1351-2. PubMed ID: 26139846
[No Abstract] [Full Text] [Related]
18. Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
Pagano L; Caira M; Candoni A; Aversa F; Castagnola C; Caramatti C; Cattaneo C; Delia M; De Paolis MR; Di Blasi R; Di Caprio L; Fanci R; Garzia M; Martino B; Melillo L; Mitra ME; Nadali G; Nosari A; Picardi M; Potenza L; Salutari P; Trecarichi EM; Tumbarello M; Verga L; Vianelli N; Busca A;
Clin Infect Dis; 2012 Dec; 55(11):1515-21. PubMed ID: 22955439
[TBL] [Abstract][Full Text] [Related]
19. The first suspected disseminated
Wang Q; Song Y; Han D; Cai H; Yan Q; Liu W; Wang H; Zheng X; Ding L; Yuan X
Emerg Microbes Infect; 2023 Dec; 12(1):2220581. PubMed ID: 37254739
[No Abstract] [Full Text] [Related]
20. Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.
Wu CH; Lu PL; Hsiao HH; Liu TC; Lin SF; Chang CS; Hsu JF; Liu YC
Ann Hematol; 2014 Jun; 93(6):1079-81. PubMed ID: 24170227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
